Hepion Pharmaceuticals, Inc.
HEPA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $906 | $1,219 | $3,272 |
| - Cash | $2,321 | $2,924 | $4,586 | $406 |
| + Debt | $0 | $372 | $526 | $2,900 |
| Enterprise Value | – | -$1,646 | -$2,841 | $5,765 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$457 | -$1,335 | -$6,081 | $3,230 |
| % Margin | – | – | – | – |
| Net Income | -$473 | -$1,043 | -$6,106 | -$1,547 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.04 | -0.09 | -2.15 | -11.12 |
| % Growth | 55.6% | 95.8% | 80.7% | – |
| Operating Cash Flow | -$446 | -$1,375 | -$1,117 | -$1,153 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$446 | -$1,375 | -$1,117 | -$1,153 |